← All candidates
Two insider buys in the last year — $55.4K in all.
40 filings on record.
ADVAdvantage Solutions Inc.
NasdaqGS · Communication Services · $443.00M
$33.45
+1.58% · Sep 16
Two insider buys in the last year — $55.4K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ADV ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$443.00M
Float
4.5M
34% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
4.3
Price / sales
0.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Kilts James M
Bought $32.0K on May 27 — 26,523 sh @ $1.21, held direct, 2.4% of their stake.
0 of 1 position beat the S&P
Chief Executive Officer
Peacock David A
Bought $27.7K on May 19 — 800 sh @ $34.60, held direct, 0.4% of their stake.
No completed positions to measure
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
35 more transactions on Pro →Context
Wall St
$42.50 avg target
+27.1% vs today · 2 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$2.88 act−$4.39
Q1 '26−$5.49 act−$1.75
Q4 '25−$0.46 act−$3.21
Q3 '25$1.83 act−$4.07
Coverage
How The Story On Advanced Enzyme Technologies (NSEI:ADVENZYMES) Is Evolving Around A ₹370 Fair ValueSimply Wall St. · 05-13Earnings Update: Here's Why Analysts Just Lifted Their Advantage Solutions Inc. (NASDAQ:ADV) Price Target To US$42.50Simply Wall St. · 05-08Advantage Solutions (ADV) Q1 2026 Earnings TranscriptMotley Fool · 05-07Advantage Solutions Inc. Q1 2026 Earnings Call SummaryMoby · 05-06
The file stays open
40 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice